Loading
A phase 2 trial of capecitabine in pancreatic cancer, run by Proton Collaborative Group, now recruiting.
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas is a phase 2, interventional study registered as NCT02598349 by Proton Collaborative Group, with a registry enrolment figure of 60 participants, started 2016-04 and due to reach its primary completion in 2039-10. Interventions recorded: Proton Radiation; Capecitabine; Surgical resection. Conditions listed: Pancreatic Cancer. Primary outcome: Overall survival at 12 months after radiation therapy. Pancreatic eligibility wording from the registry: "* Biopsy proven unresectable adenocarcinoma of the pancreas". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), IMRT / IGRT (modern external beam), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.